Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 93 | 0.91 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 16433
Sealed predictions
- ARL8B in dopamine neurons, braak+0.53 (p 0.146) → +0.04 (p 0.928)receipt 16440
Swarm cases
receipt 16440: ARL8B in dopamine neurons, braak
- power
- full sample +0.49 (p 0.040, n 18), 95% CI +0.03 to +0.78. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.53 (p 0.025, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.57 (p 0.014, n 18). not the mix.
- skeptic
- leave-one-out range +0.41 to +0.59, sign flips 0; without severely affected donors +0.49 (p 0.040, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ARL8B in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts